Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B

Nephrology Dialysis Transplantation

Volumn 30, Issue 5, 2015, Pages 862-864

  Imamura, Hideaki ^a,b   Konomoto, Takao ^a,b   Tanaka, Etsuko ^a   Hisano, Satoshi ^c   Yoshida, Yoko ^d   Fujimura, Yoshihiro ^d   Miyata, Toshiyuki ^b   Nunoi, Hiroyuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

C3 glomerulonephritis; complement alternative pathway; complement factor B; genetic mutation

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLOSPORIN; STEROID;

ARTICLE; C3 GLOMERULONEPHRITIS; CASE REPORT; CHILD; COMPLEMENT FACTOR B GENE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GAIN OF FUNCTION MUTATION; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; HEMATURIA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MEDICAL HISTORY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; ADOLESCENT; BIOPSY; FAMILY HEALTH; GENETICS; HETEROZYGOTE; KIDNEY; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADOLESCENT; BIOPSY; CHILD; COMPLEMENT FACTOR B; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMATURIA; HETEROZYGOTE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MUTATION; PROTEINURIA;

EID: 84929583971     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv054     Document Type: Article

References (10)

1. Fakhouri F, Frémeaux-Bacchi V, Noël L-H et al. C3 glomerulopathy: A new classification. Nat Rev Nephrol 2010; 6: 494-499
2. Sethi S, Fervenza FC, Zhang Y et al. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 2011; 6: 1009-1017
3. Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol 2012; 8: 634-642
4. Barbour TD, Pickering MC, Cook HT. Recent insights into C3 glomerulopathy. Nephrol Dial Transplant 2013; 28: 1685-1693
5. Sethi S, Nester CM, Smith RJH. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 2012; 81: 434-441
6. Pickering MC, D'Agati VD, Nester CM et al. C3 glomerulopathy: consensus report. Kidney Int 2013; 84: 1079-1089
7. Fan X, Yoshida Y, Honda S et al. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol 2013; 54: 238-246
8. Marinozzi MC, Vergoz L, Rybkine T et al. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? J Am Soc Nephrol 2014; 25: 2053-2065
9. Hourcade DE, Mitchell LM, Oglesby TJ. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding. J Immunol 1999; 162: 2906-2911
10. Yuasa I, Nakagawa M, Umetsu K et al. Molecular basis of complement factor I (CFI) polymorphism: one of two polymorphic suballeles responsible for CFI A is Japanese-specific. J Hum Genet 2008; 53: 1016-1021